|
|
||||||||
1From the Departments of Epidemiology and Biostatistics and 2Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; 3The Netherlands Ophthalmic Research Institute, Royal Academy of Arts and Sciences (KNAW), Amsterdam, The Netherlands; and 4Department of Ophthalmology, Academic Medical Center, Amsterdam, The Netherlands.
PURPOSE. To determine whether blood pressure and subclinical atherosclerosis are associated with incident age-related maculopathy (ARM).
METHODS. The study was performed within the Rotterdam Study, a population-based, prospective cohort study in Rotterdam, The Netherlands. A total of 4822 subjects who at baseline were aged 55 years more, were free of ARM, and participated in at least one of two follow-up examinations after a mean of 2 and 6.5 years, were included in the study. At baseline, blood pressure and the presence of atherosclerosis were determined. ARM was assessed according to the International Classification and Grading System and defined as large, soft drusen with pigmentary changes; indistinct drusen; or atrophic or neovascular age-related macular degeneration.
RESULTS. After a mean follow-up of 5.2 years, incident ARM was diagnosed in 417 subjects. Increased systolic blood pressure or pulse pressure was associated with a higher risk of ARM. Adjusted for age, gender, smoking, total and high-density lipoprotein cholesterol, body mass index, and diabetes mellitus, odds ratios (OR) per 10-mm Hg increase were 1.08 (95% confidence interval [CI]: 1.031.14) and 1.11 (95% CI: 1.041.18), respectively. Moreover, different measures of atherosclerosis were associated with the risk of ARM. An increase in carotid wall thickness (OR per 1 SD, 1.15; 95% CI: 1.031.28) increased the risk of ARM. The lowest compared with the highest tertile of anklearm index had an OR of 1.32 (95% CI: 1.001.75). A weak association was found between aortic calcifications and the risk of ARM.
CONCLUSIONS. Elevated systolic blood or pulse pressure or the presence of atherosclerosis may increase the risk of development of ARM.
This article has been cited by other articles:
![]() |
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, S. Ohno, Y. Oike, and S. Ishida Inhibition of Choroidal Neovascularization with an Anti-Inflammatory Carotenoid Astaxanthin Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1679 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2555 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, A. Hofman, and P. T. V. M. de Jong C-reactive Protein Level and Risk of Aging Macula Disorder: The Rotterdam Study Arch Ophthalmol, October 1, 2007; 125(10): 1396 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al. Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. L. Tan, P. Mitchell, A. Kifley, V. Flood, W. Smith, and J. J. Wang Smoking and the Long-term Incidence of Age-Related Macular Degeneration: The Blue Mountains Eye Study Arch Ophthalmol, August 1, 2007; 125(8): 1089 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cugati, R. G. Cumming, W. Smith, G. Burlutsky, P. Mitchell, and J. J. Wang Visual Impairment, Age-Related Macular Degeneration, Cataract, and Long-term Mortality: The Blue Mountains Eye Study Arch Ophthalmol, July 1, 2007; 125(7): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izumi-Nagai, N. Nagai, Y. Ozawa, M. Mihara, Y. Ohsugi, T. Kurihara, T. Koto, S. Satofuka, M. Inoue, K. Tsubota, et al. Interleukin-6 Receptor-Mediated Activation of Signal Transducer and Activator of Transcription-3 (STAT3) Promotes Choroidal Neovascularization Am. J. Pathol., June 1, 2007; 170(6): 2149 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al. Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2321 - 2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Klein, B. E. K. Klein, M. D. Knudtson, M. F. Cotch, T. Y. Wong, K. Liu, G. L. Burke, M. F. Saad, D. R. Jacobs Jr, and A. R. Sharrett Subclinical Atherosclerotic Cardiovascular Disease and Early Age-Related Macular Degeneration in a Multiracial Cohort: The Multiethnic Study of Atherosclerosis Arch Ophthalmol, April 1, 2007; 125(4): 534 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cheung, D. Liao, F M Amirul Islam, R. Klein, J. Jin Wang, and T. Yin Wong Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study Br. J. Ophthalmol., April 1, 2007; 91(4): 430 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Munch, B. Sander, L. Kessel, J. L. Hougaard, N. C. B. B. Taarnhoj, T. I. A. Sorensen, K. O. Kyvik, and M. Larsen Heredity of Small Hard Drusen in Twins Aged 20-46 Years Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tummala, M. Ali, P. Getty, P. M. Hocking, D. W. Burt, C. F. Inglehearn, and D. H. Lester Mutation in the Guanine Nucleotide-Binding Protein {beta}-3 Causes Retinal Degeneration and Embryonic Mortality in Chickens Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4714 - 4718. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Urano, Y. Kubota, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, T. Suda, et al. Angiotensin II Type 1 Receptor-Mediated Inflammation Is Required for Choroidal Neovascularization Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2252 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Xu, Y Li, Y Zheng, and J B Jonas Associated factors for age related maculopathy in the adult population in China: the Beijing eye study Br. J. Ophthalmol., September 1, 2006; 90(9): 1087 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wong, R. Klein, C. Sun, P. Mitchell, D. J. Couper, H. Lai, L. D. Hubbard, A. R. Sharrett, and for the Atherosclerosis Risk in Communities Study Age-Related Macular Degeneration and Risk for Stroke Ann Intern Med, July 18, 2006; 145(2): 98 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chua, V. Flood, E. Rochtchina, J. J. Wang, W. Smith, and P. Mitchell Dietary Fatty Acids and the 5-Year Incidence of Age-Related Maculopathy Arch Ophthalmol, July 1, 2006; 124(7): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Mainster Violet and blue light blocking intraocular lenses: photoprotection versus photoreception Br. J. Ophthalmol., June 1, 2006; 90(6): 784 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Arroyo A 76-year-old man with macular degeneration. JAMA, May 24, 2006; 295(20): 2394 - 2406. [Full Text] [PDF] |
||||
![]() |
T I Metelitsina, J E Grunwald, J C DuPont, and G-S Ying Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br. J. Ophthalmol., March 1, 2006; 90(3): 342 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. McGwin Jr, K. Modjarrad, T. A. Hall, A. Xie, and C. Owsley 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Presence of Age-Related Macular Degeneration in the Cardiovascular Health Study Arch Ophthalmol, January 1, 2006; 124(1): 33 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Leeuwen, S. Boekhoorn, J. R. Vingerling, J. C. M. Witteman, C. C. W. Klaver, A. Hofman, and P. T. V. M. de Jong Dietary Intake of Antioxidants and Risk of Age-Related Macular Degeneration JAMA, December 28, 2005; 294(24): 3101 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J L Duncan Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration Br. J. Ophthalmol., December 1, 2005; 89(12): 1549 - 1551. [Full Text] [PDF] |
||||
![]() |
B. Dasch, A. Fuhs, T. Behrens, A. Meister, J. Wellmann, M. Fobker, D. Pauleikhoff, and H.-W. Hense Inflammatory Markers in Age-Related Maculopathy: Cross-sectional Analysis From the Muenster Aging and Retina Study Arch Ophthalmol, November 1, 2005; 123(11): 1501 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sivaprasad, N. V. Chong, and T. A. Bailey Serum Elastin-Derived Peptides in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3046 - 3051. [Abstract] [Full Text] [PDF] |
||||
![]() |
H A Moeini, H Masoudpour, and H Ghanbari A study of the relation between body mass index and the incidence of age related macular degeneration Br. J. Ophthalmol., August 1, 2005; 89(8): 964 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernandez-Robredo, D. Moya, J. A. Rodriguez, and A. Garcia-Layana Vitamins C and E Reduce Retinal Oxidative Stress and Nitric Oxide Metabolites and Prevent Ultrastructural Alterations in Porcine Hypercholesterolemia Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1140 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mainster Intraocular Lenses Should Block UV Radiation and Violet but Not Blue Light Arch Ophthalmol, April 1, 2005; 123(4): 550 - 555. [Full Text] [PDF] |
||||
![]() |
E Friedman Update of the vascular model of AMD Br. J. Ophthalmol., February 1, 2004; 88(2): 161 - 163. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |